Skip to main content
Fig. 8 | Cancer Nanotechnology

Fig. 8

From: Folic acid-functionalized PEGylated niosomes co-encapsulated cisplatin and doxoribicin exhibit enhanced anticancer efficacy

Fig. 8

A Impacts of empty niosomes, DOX + CIS, DOX + CIS-Nio, and DOX + CIS-Nio@PEG–FA on cell cycle arrest after 48 h of treatment on A2780 cancer cells. B Impacts of empty niosomes, DOX + CIS, DOX + CIS-Nio, and DOX + CIS-Nio@PEG–FA on cell cycle arrest after 48 h of treatment on MCF7 cells; Data represent means ± standard deviations (n = 3), For all graphs, ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The control sample refers to the cells without treatment

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us